Hebei Kaiwei Pharma And Canadian Food Company Sign Joint Venture Agreement
This article was originally published in PharmAsia News
Executive SummaryAfter six months of communication, Hebei Kaiwei Pharmaceutical and a Canadian food company recently signed a joint venture agreement to develop an emulsifying agent treatment for burns, bed sores, hemorrhoids, psoriasis, and other diseases
You may also be interested in...
In joint complaint, the FTC and New York Attorney General allege scheme to block generic Daraprim and maintain exorbitant list price; they cite hundreds of emails the incarcerated Shkreli has exchanged with co-defendant in last six months.
Biogen value-based contract with UPMC Health Plan ties payments to patient-reported outcomes for Tecfidera and Avonex. The company may seek something similar for Vumerity.
As interest in immune/inflammatory disease increases and savings achieved dip, payer focus on patient-reported outcomes for contracts reflects shift in focus, Avalere survey suggests.